Screener
Kiora Pharmaceuticals, Inc. KPRX Q4 2025 Annual earnings
Reported March 25, 2026 · Before market open
EPS-$1.60Miss by $0.93
Revenue estimate$1.5M
EPS estimate-$0.67
Next report
Nov 6, 2026 (in 2 months)EPS estimate-$0.38
Versus estimates
Diluted EPS
FAQ
- When did Kiora Pharmaceuticals, Inc. report Q4 2025 earnings?
- Kiora Pharmaceuticals, Inc. (KPRX) reported Q4 2025 earnings on March 25, 2026 before market open.
- What were Kiora Pharmaceuticals, Inc.'s Q4 2025 revenue and EPS?
- Kiora Pharmaceuticals, Inc. reported eps of $-1.60 for Q4 2025.
- Did Kiora Pharmaceuticals, Inc. beat estimates in Q4 2025?
- EPS missed the consensus estimate of $-0.67 by $0.93.
- How did Kiora Pharmaceuticals, Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 53.8% from $-1.04.
- Where can I find Kiora Pharmaceuticals, Inc.'s Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001372514-26-000025) and the 10-K periodic report (0001372514-26-000024) directly on SEC EDGAR. The filing index links above go to sec.gov.
